13.10.2015 • NewsDede WillamsTevageneric

Teva Launches Generic Dutasteride

Israeli generics giant Teva Pharmaceutical Industries has launched a generic equivalent to Glaxo SmithKline’s Avodart (dutasteride) 0.5 mg capsules on the US market.

The active ingredient dutasteride, a 5 alpha-reductase enzyme inhibitor, works by lowering production of the hormone dihydrotestosterone (DHT and is used to treat the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

First drugmaker to file for a generic application, Teva said it expects its product to be exclusive for several weeks. GlaxoSmithKline has annual sales of about $467 million from the capsules.

 

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.